Sivia Capital Partners LLC Takes Position in DaVita Inc. (NYSE:DVA)

Sivia Capital Partners LLC acquired a new stake in DaVita Inc. (NYSE:DVA) during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm acquired 1,594 shares of the company’s stock, valued at approximately $220,000.

Several other hedge funds have also modified their holdings of the stock. Sumitomo Mitsui Trust Holdings Inc. raised its stake in shares of DaVita by 1.6% in the first quarter. Sumitomo Mitsui Trust Holdings Inc. now owns 134,823 shares of the company’s stock valued at $18,612,000 after acquiring an additional 2,129 shares in the last quarter. Panoramic Investment Advisors LLC purchased a new position in shares of DaVita during the first quarter worth about $203,000. Dumont & Blake Investment Advisors LLC grew its holdings in shares of DaVita by 2.1% during the first quarter. Dumont & Blake Investment Advisors LLC now owns 8,290 shares of the company’s stock worth $1,144,000 after purchasing an additional 170 shares during the last quarter. Fox Hill Wealth Management grew its holdings in shares of DaVita by 138.4% during the first quarter. Fox Hill Wealth Management now owns 15,734 shares of the company’s stock worth $2,172,000 after purchasing an additional 9,135 shares during the last quarter. Finally, Atlas Capital Advisors LLC grew its holdings in shares of DaVita by 137.0% during the first quarter. Atlas Capital Advisors LLC now owns 6,254 shares of the company’s stock worth $863,000 after purchasing an additional 3,615 shares during the last quarter. 90.12% of the stock is currently owned by institutional investors and hedge funds.

Insider Buying and Selling at DaVita

In other DaVita news, Director Barbara J. Desoer sold 5,030 shares of DaVita stock in a transaction that occurred on Friday, May 10th. The stock was sold at an average price of $138.81, for a total value of $698,214.30. Following the sale, the director now owns 10,954 shares of the company’s stock, valued at approximately $1,520,524.74. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. 2.00% of the stock is owned by corporate insiders.

Analyst Upgrades and Downgrades

DVA has been the topic of several research reports. StockNews.com lowered DaVita from a “strong-buy” rating to a “buy” rating in a report on Saturday, June 8th. Truist Financial raised their price objective on DaVita from $135.00 to $150.00 and gave the stock a “hold” rating in a report on Wednesday, May 15th. Finally, Barclays raised their price target on DaVita from $133.00 to $150.00 and gave the stock an “equal weight” rating in a report on Monday, May 6th. Two investment analysts have rated the stock with a hold rating and two have issued a buy rating to the company. According to MarketBeat, the stock currently has an average rating of “Moderate Buy” and a consensus price target of $144.67.

DaVita Stock Performance

Shares of NYSE DVA traded down $0.10 during midday trading on Wednesday, reaching $138.35. 219,123 shares of the company were exchanged, compared to its average volume of 869,188. The company has a current ratio of 1.43, a quick ratio of 1.37 and a debt-to-equity ratio of 7.95. DaVita Inc. has a 1 year low of $71.51 and a 1 year high of $147.93. The stock has a fifty day simple moving average of $139.93 and a 200 day simple moving average of $127.32. The stock has a market cap of $12.13 billion, a P/E ratio of 15.73, a PEG ratio of 1.06 and a beta of 0.87.

DaVita (NYSE:DVA) last released its quarterly earnings results on Thursday, May 2nd. The company reported $2.38 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.95 by $0.43. DaVita had a return on equity of 68.52% and a net margin of 6.61%. The firm had revenue of $3.07 billion for the quarter, compared to analyst estimates of $3.03 billion. During the same quarter last year, the company posted $1.58 earnings per share. The business’s revenue was up 6.9% on a year-over-year basis. On average, research analysts forecast that DaVita Inc. will post 9.62 earnings per share for the current fiscal year.

DaVita Profile

DaVita Inc provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers.